BG49717A3 - Метод за получаване на хирудин - Google Patents
Метод за получаване на хирудинInfo
- Publication number
- BG49717A3 BG49717A3 BG077615A BG7761586A BG49717A3 BG 49717 A3 BG49717 A3 BG 49717A3 BG 077615 A BG077615 A BG 077615A BG 7761586 A BG7761586 A BG 7761586A BG 49717 A3 BG49717 A3 BG 49717A3
- Authority
- BG
- Bulgaria
- Prior art keywords
- hirudin
- mature
- obtaining
- obtaining hirudin
- yeast
- Prior art date
Links
- 102000007625 Hirudins Human genes 0.000 title abstract 4
- 108010007267 Hirudins Proteins 0.000 title abstract 4
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 title abstract 4
- 229940006607 hirudin Drugs 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 1
- 239000003146 anticoagulant agent Substances 0.000 abstract 1
- 229940127219 anticoagulant drug Drugs 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
- C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Instructional Devices (AREA)
- Yarns And Mechanical Finishing Of Yarns Or Ropes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8506672A FR2593518B1 (fr) | 1985-05-02 | 1985-05-02 | Vecteurs d'expression et de secretion de l'hirudine par les levures transformees |
| PCT/FR1986/000153 WO1986006406A1 (fr) | 1985-05-02 | 1986-05-02 | Vecteurs d'expression et de secretion de l'hirudine par les levures transformees |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG49717A3 true BG49717A3 (bg) | 1992-01-15 |
Family
ID=9318888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG077615A BG49717A3 (bg) | 1985-05-02 | 1986-12-19 | Метод за получаване на хирудин |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0200655B1 (de) |
| JP (2) | JP2580141B2 (de) |
| KR (1) | KR870700234A (de) |
| AT (1) | ATE121778T1 (de) |
| AU (1) | AU600667B2 (de) |
| BG (1) | BG49717A3 (de) |
| CA (1) | CA1341501C (de) |
| CZ (1) | CZ282928B6 (de) |
| DE (1) | DE3650306T2 (de) |
| DK (1) | DK174837B1 (de) |
| ES (1) | ES8703930A1 (de) |
| FI (1) | FI104635B (de) |
| FR (2) | FR2593518B1 (de) |
| HK (1) | HK1006183A1 (de) |
| HU (1) | HU202919B (de) |
| IE (1) | IE67136B1 (de) |
| MC (1) | MC1785A1 (de) |
| NO (1) | NO302375B1 (de) |
| PL (1) | PL155074B1 (de) |
| PT (1) | PT82490B (de) |
| RU (1) | RU1774950C (de) |
| WO (1) | WO1986006406A1 (de) |
| ZA (1) | ZA863261B (de) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3738541A1 (de) * | 1987-11-13 | 1989-05-24 | Hoechst Ag | Verfahren zur isolierung und reinigung von hirudin |
| FR2593518B1 (fr) * | 1985-05-02 | 1989-09-08 | Transgene Sa | Vecteurs d'expression et de secretion de l'hirudine par les levures transformees |
| GB8530631D0 (en) | 1985-12-12 | 1986-01-22 | Ciba Geigy Ag | Thrombin inhibitors |
| MY101203A (en) * | 1985-12-12 | 1991-08-17 | Ucp Gen Pharma Ag | Production of thrombin iinhibitors. |
| FR2607516B2 (fr) * | 1986-12-01 | 1989-12-22 | Transgene Sa | Vecteurs perfectionnes d'expression d'un variant de l'hirudine dans les levures, procede et produit obtenu |
| MC1834A1 (fr) * | 1986-07-10 | 1988-06-03 | Transgene Sa | Bloc fonctionnel d'adn et plasmide codant pour l'hirudine,levure transformee,procede de preparation de l'hirudine,hirudine obtenue et son utilisation |
| FR2607517B2 (fr) * | 1986-12-01 | 1989-12-22 | Transgene Sa | Vecteurs d'expression de variants de l'hirudine dans les levures, procede et produit obtenu |
| FR2611723B1 (fr) * | 1987-02-27 | 1989-09-08 | Transgene Sa | Vecteur d'expression d'adn recombinant codant pour l'hirudine, cultures de cellules de mammiferes infectees ou transformees, procede de preparation de l'hirudine et proteine obtenue |
| JPH03503596A (ja) * | 1987-06-24 | 1991-08-15 | ノボ・ノルディスク エー/エス | 蛋白質若しくはポリペプチドの調製方法、該ポリペプチドをコードするdna配列、該dna配列およびポリペプチドを有する微生物および該ポリペプチドの薬学的製剤としての利用 |
| US5256559A (en) * | 1988-03-04 | 1993-10-26 | Biogen, Inc. | Methods and compositions for inhibiting platelet aggregation |
| DE3819079A1 (de) * | 1988-06-04 | 1989-12-07 | Hoechst Ag | Hirudin-derivate mit verzoegerter wirkung |
| HU213571B (en) * | 1988-07-23 | 1997-08-28 | Delta Biotechnology Ltd | Process for producing peptides and dna sequences |
| DE3835815A1 (de) * | 1988-10-21 | 1990-04-26 | Hoechst Ag | Neue isohirudine |
| US5053453A (en) * | 1988-11-01 | 1991-10-01 | Baxter International Inc. | Thromboresistant materials and methods for making same |
| CA2000887A1 (en) * | 1988-11-01 | 1990-05-01 | Cecilia S.L. Ku | Thromboresistant materials and methods for making same |
| FR2646437B1 (fr) * | 1989-04-28 | 1991-08-30 | Transgene Sa | Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant |
| DE4009268A1 (de) * | 1990-03-22 | 1991-09-26 | Consortium Elektrochem Ind | Sekretion von hirudinderivaten |
| US6514730B1 (en) | 1991-03-21 | 2003-02-04 | Consortium für elektrochemische Industrie GmbH | Secretion of hirudin derivatives |
| US5837808A (en) * | 1991-08-20 | 1998-11-17 | Baxter International Inc. | Analogs of hirudin |
| DE4140381A1 (de) * | 1991-12-07 | 1993-06-09 | Hoechst Ag, 6230 Frankfurt, De | Neue synthetische isohirudine mit verbesserter stabilitaet |
| EP1031628A1 (de) * | 1992-09-04 | 2000-08-30 | Novartis AG | Verfahren zur Herstellung von Proteaseinhibitoren |
| US6500645B1 (en) | 1994-06-17 | 2002-12-31 | Novo Nordisk A/S | N-terminally extended proteins expressed in yeast |
| ZA954983B (en) * | 1994-06-17 | 1996-02-14 | Novo Nordisk As | N-terminally extended proteins expressed in yeast |
| DE19529997C1 (de) * | 1995-08-16 | 1997-04-10 | Hoechst Ag | Verfahren zur Inaktivierung von Carboxypeptidase Y in hirudinhaltigen Kulturbrühen |
| DE19543737A1 (de) * | 1995-11-24 | 1997-05-28 | Hoechst Ag | Verfahren zur Ultrafiltration von Peptide oder Proteine enthaltender biologischer Matrices |
| DE19544233A1 (de) | 1995-11-28 | 1997-06-05 | Hoechst Ag | Verfahren zur Nutzung des Hefe-ADH II-Promotorsystems zur biotechnologischen Produktion heterologer Proteine in hohen Ausbeuten |
| ZA9610456B (en) * | 1995-12-20 | 1997-06-20 | Novo Nordisk As | N-terminally extended proteins expressed in yeast |
| EP0787569B1 (de) | 1996-01-31 | 2002-10-02 | Sumitomo Bakelite Company Limited | Verfahren zur Herstellung von in Epoxyharz eingekapselter Halbleitervorrichtung |
| US6265204B1 (en) * | 1997-01-17 | 2001-07-24 | Genencor International, Inc. | DNA sequences, vectors, and fusion polypeptides for secretion of polypeptides in filamentous fungi |
| US7202059B2 (en) | 2001-02-20 | 2007-04-10 | Sanofi-Aventis Deutschland Gmbh | Fusion proteins capable of being secreted into a fermentation medium |
| US7638618B2 (en) | 2001-02-20 | 2009-12-29 | Sanofi-Aventis Deutschland Gmbh | Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest |
| DE10149678A1 (de) | 2001-10-09 | 2009-03-12 | Novel Science International Gmbh | Organische Verbindungen mit biologischer Wirkung als Thrombinhemmer und ihre Verwendung |
| DE10301255A1 (de) | 2003-01-15 | 2004-07-29 | Cpi Creative Pharma International Gmbh | Organische Verbindungen mit biologischer Wirkung als Thrombinhemmer und ihre Verwendung |
| US7795205B2 (en) | 2004-04-12 | 2010-09-14 | Canyon Pharmaceuticals, Inc. | Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3382547D1 (de) * | 1983-01-12 | 1992-05-27 | Chiron Corp | Sekretorische expression in eukaryoten. |
| AU572125B2 (en) * | 1983-03-17 | 1988-05-05 | Mabco Limited | Monoclonal antibodies with specificity for crosslinked fibrin and their diagnotic uses |
| WO1984004330A1 (en) * | 1983-04-22 | 1984-11-08 | Amgen | Secretion of exogenous polypeptides from yeast |
| NZ207926A (en) * | 1983-04-25 | 1988-04-29 | Genentech Inc | Use of yeast #a#-factor to assist in expression of proteins heterologus to yeast |
| JPS6041487A (ja) * | 1983-04-25 | 1985-03-05 | ジエネンテツク・インコ−ポレイテツド | 酵母発現系でのアルフア因子配列の使用 |
| JPS59227899A (ja) * | 1983-05-25 | 1984-12-21 | チロン・コ−ポレイシヨン | 成長ホルモン放出因子の製造方法 |
| DE3586333T2 (de) * | 1984-03-27 | 1992-12-10 | Transgene Sa | Expressionsvektoren fuer hirudin, transformierte zellen und verfahren zur herstellung von hirudin. |
| ATE64956T1 (de) * | 1984-06-14 | 1991-07-15 | Ciba Geigy Ag | Verfahren zur herstellung von thrombininhibitoren. |
| DE3429430A1 (de) * | 1984-08-10 | 1986-02-20 | Hoechst Ag, 6230 Frankfurt | Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens |
| DE3445517C2 (de) * | 1984-12-13 | 1993-11-18 | Ciba Geigy | Für ein Hirudin-ähnliches Protein codierende DNA-Sequenz und Verfahren zur Herstellung eines Hirudin-ähnlichen Proteins |
| FR2593518B1 (fr) * | 1985-05-02 | 1989-09-08 | Transgene Sa | Vecteurs d'expression et de secretion de l'hirudine par les levures transformees |
-
1985
- 1985-05-02 FR FR8506672A patent/FR2593518B1/fr not_active Expired
-
1986
- 1986-04-30 ZA ZA863261A patent/ZA863261B/xx unknown
- 1986-04-30 PT PT82490A patent/PT82490B/pt unknown
- 1986-04-30 CA CA000508053A patent/CA1341501C/fr not_active Expired - Fee Related
- 1986-05-02 KR KR860700971A patent/KR870700234A/ko not_active Ceased
- 1986-05-02 PL PL1986259298A patent/PL155074B1/pl unknown
- 1986-05-02 ES ES555121A patent/ES8703930A1/es not_active Expired
- 1986-05-02 AT AT86400961T patent/ATE121778T1/de not_active IP Right Cessation
- 1986-05-02 JP JP61502537A patent/JP2580141B2/ja not_active Expired - Lifetime
- 1986-05-02 WO PCT/FR1986/000153 patent/WO1986006406A1/fr not_active Ceased
- 1986-05-02 DE DE3650306T patent/DE3650306T2/de not_active Expired - Lifetime
- 1986-05-02 HU HU863185A patent/HU202919B/hu unknown
- 1986-05-02 IE IE118386A patent/IE67136B1/en not_active IP Right Cessation
- 1986-05-02 EP EP86400961A patent/EP0200655B1/de not_active Expired - Lifetime
- 1986-05-02 MC MC86FR8600153D patent/MC1785A1/xx unknown
- 1986-05-02 AU AU57787/86A patent/AU600667B2/en not_active Expired
- 1986-05-04 CZ CS863217A patent/CZ282928B6/cs not_active IP Right Cessation
- 1986-07-10 FR FR868610090A patent/FR2601383B2/fr not_active Expired
- 1986-12-19 BG BG077615A patent/BG49717A3/xx unknown
- 1986-12-23 FI FI865303A patent/FI104635B/fi not_active IP Right Cessation
- 1986-12-30 DK DK198606343A patent/DK174837B1/da not_active IP Right Cessation
- 1986-12-30 NO NO865336A patent/NO302375B1/no not_active IP Right Cessation
- 1986-12-30 RU SU864028760A patent/RU1774950C/ru active
-
1996
- 1996-03-26 JP JP8070208A patent/JP2779930B2/ja not_active Expired - Lifetime
-
1998
- 1998-06-12 HK HK98105246A patent/HK1006183A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG49717A3 (bg) | Метод за получаване на хирудин | |
| BG47033A3 (en) | Method for preparing of derivatives of imidazolamine | |
| GEP20084347B (en) | New derivatives of diphosphonic acid, method for their preparation and medicamentous form containing them | |
| FR2656337B1 (fr) | Electrode generatrice d'oxygene et procede pour sa preparation. | |
| HUT47261A (en) | Process for production of new tiasole-derivatives effecting on the cholinerg-system and medical compositions containing these substances | |
| GR860571B (en) | Labdan-derivatives process for their preparation and their use as medicaments | |
| BG35465A3 (en) | Method for preparing derivatives of 1-(cyclohexyl)-4-aryl-4- piperidine carbonic acid | |
| HUT46907A (en) | Process for production of derivatives of 1,4-dihydropiridine and medical preparatives containing such substances | |
| IT1138511B (it) | Procedimento per la produzione di un concentrato spinto di fattore viii(ahf) | |
| ATE95564T1 (de) | Aeusseres membranprotein f von pseudomonas aeruginosa. | |
| FR2607517B2 (fr) | Vecteurs d'expression de variants de l'hirudine dans les levures, procede et produit obtenu | |
| HU911811D0 (en) | Process for the production of acylized alpha, omega-amino-alcoholic derivatives and for using them in pesticide substances | |
| IL77668A (en) | Production of cholecalciferol derivatives and novel intermediates used therefor | |
| GB2199036B (en) | New furanuronic acid derivatives, process for their production and their use | |
| CS274677B2 (en) | Method of 7-piperazino-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxyl acid's derivatives production | |
| DE3171100D1 (en) | Process for separation of products containing propolis and products containing propolis | |
| HUT45972A (en) | Process for production of derivatives of subsituated amin-methil-5,6,7,8-tetrahydronaphtil-oxi-acetic acid, of medical compositions containing such substances and also of the intermediers | |
| ZA857721B (en) | Process for treatment of rheumatic diseases | |
| DE3561719D1 (en) | Process for the preparation of symmetrical benzophenones substituted by fluor-containing groups, their use and symmetrical benzophenones substituted by fluor-containing groups | |
| IL77661A (en) | Process for the preparation of 4,4-azetidinones,and novel intermediates thereof | |
| GR3001052T3 (en) | Novel 16,17-acetalsubstituted pregnane-21-oic acid derivatives, process for the preparation thereof and pharmaceutical preparation containing them | |
| HUT40644A (en) | Process for production of new derivatives of 1,4-dihydropiridin-3,5-dicarbonic acid esther and medical preparatives containing thereof | |
| BG40653A3 (en) | Method for preparing amidothiocarbamate derivatives of carbon acid | |
| EP0226558A3 (en) | Chemical intermediates and methods for their preparation | |
| HU9200792D0 (en) | Diphosphinic acid derivatives containing new amidine-groups, process for their production and medical preparations containing thereof |